074430 — AMINOLOGICS CO Balance Sheet
0.000.00%
- KR₩85bn
- KR₩55bn
- KR₩17bn
Annual balance sheet for AMINOLOGICS CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 25,383 | 25,663 | 29,238 | 28,499 | 35,382 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,833 | 6,517 | 5,710 | 8,560 | 4,838 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 35,325 | 38,679 | 43,569 | 45,249 | 46,517 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,585 | 2,120 | 2,826 | 2,630 | 3,090 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 60,129 | 65,243 | 55,582 | 57,668 | 56,789 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,047 | 5,381 | 3,429 | 2,668 | 4,342 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,571 | 5,849 | 4,178 | 3,257 | 5,094 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 53,558 | 59,393 | 51,404 | 54,411 | 51,695 |
| Total Liabilities & Shareholders' Equity | 60,129 | 65,243 | 55,582 | 57,668 | 56,789 |
| Total Common Shares Outstanding |